National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 681370

Case Details

VAERS ID: 681370 (history)  
Age:   
Gender: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2016-02-23
Submitted: 2017-02-06
   Days after onset:349
Entered: 2017-02-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Dizziness, Fatigue, Postural orthostatic tachycardia syndrome, Tachycardia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Vestibular disorders (broad)

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Routine childhood immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: GB0095075131702GBR001295

Write-up: This spontaneous report as received from a consumer via the Agency (HA # EYC 00152376) refers to a 15 year old female patient. The patient''s medical history, concurrent conditions and concomitant medications were not reported. In 2013, the patient was vaccinated with the first dose of GARDASIL (parenteral; dose, lot # and expiration date were not reported) as routine childhood immunisation. In 2014, the patient was vaccinated with the second dose of GARDASIL (parenteral; dose, lot # and expiration date were not reported). On 23-FEB-2016, the patient experienced chronic fatigue syndrome (CFS) and postural orthostatic tachycardia syndrome (POTS). On an unknown date, the patient experienced dizziness. Seek advice details: tachycardia, dizziness and fatigue. The patient had a visit to accident and emergency 3 times. The patient had seen pediatrician and cardiologist and was waiting for nuclear magnetic resonance imaging (MRI) on heart. The outcome of the adverse events of chronic fatigue syndrome (CFS) and postural orthostatic tachycardia syndrome (POTS) was reported as not recovered. The outcome of dizziness was unknown. The relatedness between the adverse events and GARDASIL was not provided. The Agency considered the adverse events to be medically significant and disabling.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=681370


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166